Elutia (ELUT) Capital Expenditures Growth (3y) (2022 - 2026)
Elutia (ELUT) Capital Expenditures Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 2.15% |
| 10 | Elutia | 39.47 Mn | 10.98 Mn | 1.80 Mn | 36.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.12% |
| Dec 31, 2025 | 85.40% |
| Sep 30, 2025 | 75.27% |
| Jun 30, 2025 | -23.54% |
| Mar 31, 2025 | 101.46% |
| Dec 31, 2024 | 55.50% |
| Sep 30, 2024 | 77.99% |
| Jun 30, 2024 | -26.35% |
| Mar 31, 2024 | -51.44% |
| Dec 31, 2023 | -47.13% |
| Sep 30, 2023 | -47.80% |
| Jun 30, 2023 | 46.56% |
| Mar 31, 2023 | 43.18% |
| Dec 31, 2022 | -4.74% |